Position in ILMN
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$351
+$105 QoQ
Shares Held
2
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#924
of 937 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ALBION FINANCIAL GROUP /UT holds $13,727,883 across 8 Diagnostics & Research names. ILMN ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
24,162 | $12,113,860 | |
| 2 | A |
Agilent Technologies, Inc.
|
10,160 | $1,349,552 | |
| 3 | DHR |
Danaher Corp /De/
|
1,290 | $245,719 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
21 | $11,055 | |
| 5 | WAT |
Waters Corp /De/
|
15 | $5,625 | |
| 6 | LH |
Labcorp Holdings Inc.
|
6 | $1,680 | |
| 7 | ILMN |
Illumina, Inc.
This page
|
2 | $351 | |
| 8 | IMDX |
Insight Molecular Diagnostics Inc.
|
7 | $41 |
All Filings in ILMN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $351 | 2 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $246 | 2 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $262 | 2 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $189 | 2 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $190 | 2 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $158 | 2 | Shares | Sole | 2025-04-25 | |
| 2022-06-30 | $553 | 3 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $2,445 | 7 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,282 | 6 | Shares | Sole | 2022-02-15 | |
| 2020-12-31 | $19,610 | 53 | Shares | Sole | 2021-02-19 | |
| 2020-06-30 | $256,282 | 692 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $209,209 | 766 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||